Will oil’s Trump-bump last?

Donald Trump’s missile strike on Syria last week helped boost Brent crude to a four-week high of $56 a barrel. But will it last?

"Tensions in the Middle East are rising," says Andy Critchlow on BreakingViews, "but that doesn't mean the oil price has to". Donald Trump's missile strike on Syria last week helped boost Brent crude to a four-week high of $56 a barrel. Syrian production is negligible; what worries traders is that its ally Iran, which has been raising output, could retaliate. The US could then insist on further sanctions against the Islamic Republic.

Yet Iran's biggest customers, in Asia, could then keep importing Iranian oil anyway, especially if they are unsettled by US unilateralism, says Critchlow. Saudi Arabia could make up for Iranian shortfalls: "its spare capacity alone is half Iran's total output". Iran could block the Strait of Hormuz, through which a third of seaborne oil passes. But the waterway is "heavily defended".

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.